SK4695A3 - Quinoline and naphthyridine derivatives and antibacterial agent on their basis - Google Patents
Quinoline and naphthyridine derivatives and antibacterial agent on their basisInfo
- Publication number
- SK4695A3 SK4695A3 SK46-95A SK4695A SK4695A3 SK 4695 A3 SK4695 A3 SK 4695A3 SK 4695 A SK4695 A SK 4695A SK 4695 A3 SK4695 A3 SK 4695A3
- Authority
- SK
- Slovakia
- Prior art keywords
- quinoline
- basis
- antibacterial agent
- naphthyridine derivatives
- naphthyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/914,188 US5235054A (en) | 1992-07-15 | 1992-07-15 | 3-carboxaldehyde substituted quinolines and naphthyridines |
| PCT/US1993/003624 WO1994002480A1 (en) | 1992-07-15 | 1993-04-23 | Quinoline and naphthyridine prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK4695A3 true SK4695A3 (en) | 1995-07-11 |
Family
ID=25434020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK46-95A SK4695A3 (en) | 1992-07-15 | 1993-04-23 | Quinoline and naphthyridine derivatives and antibacterial agent on their basis |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5235054A (fi) |
| EP (1) | EP0650488A1 (fi) |
| JP (1) | JPH07504684A (fi) |
| KR (1) | KR950702561A (fi) |
| CN (1) | CN1083053A (fi) |
| AU (1) | AU669958B2 (fi) |
| BR (1) | BR9306733A (fi) |
| CA (1) | CA2140135A1 (fi) |
| CZ (1) | CZ280603B6 (fi) |
| FI (1) | FI933203A (fi) |
| HU (1) | HUT68745A (fi) |
| IL (1) | IL106264A0 (fi) |
| MX (1) | MX9304266A (fi) |
| NO (1) | NO950142L (fi) |
| NZ (1) | NZ252847A (fi) |
| PL (1) | PL307135A1 (fi) |
| RU (1) | RU2097379C1 (fi) |
| SK (1) | SK4695A3 (fi) |
| WO (1) | WO1994002480A1 (fi) |
| ZA (1) | ZA935076B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8448491A (en) * | 1990-09-07 | 1992-03-30 | Schering Corporation | Antiviral compounds and antihypertensive compounds |
| PL186795B1 (pl) * | 1995-12-21 | 2004-02-27 | Pfizer | Preparat farmaceutyczny zawierający danofloksacynę |
| JO3077B1 (ar) * | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
| WO2010131054A1 (en) | 2009-05-15 | 2010-11-18 | Bradford Pharma Limited | Redox drug derivatives |
| US20230192680A1 (en) * | 2019-03-11 | 2023-06-22 | Er Stress Research Institute, Inc. | NEW AGENT FOR PROMOTING PHOSPHORYLATION OF eIF2a |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2509728A1 (fr) * | 1981-07-17 | 1983-01-21 | Roussel Uclaf | Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| IN166416B (fi) * | 1985-09-18 | 1990-05-05 | Pfizer | |
| JP2777661B2 (ja) * | 1988-10-20 | 1998-07-23 | 大塚製薬株式会社 | ベンゾヘテロ環化合物 |
-
1992
- 1992-07-15 US US07/914,188 patent/US5235054A/en not_active Expired - Lifetime
-
1993
- 1993-04-23 WO PCT/US1993/003624 patent/WO1994002480A1/en not_active Application Discontinuation
- 1993-04-23 CA CA002140135A patent/CA2140135A1/en not_active Abandoned
- 1993-04-23 KR KR1019950700158A patent/KR950702561A/ko not_active Application Discontinuation
- 1993-04-23 JP JP6503987A patent/JPH07504684A/ja active Pending
- 1993-04-23 EP EP93912293A patent/EP0650488A1/en not_active Withdrawn
- 1993-04-23 CZ CZ95101A patent/CZ280603B6/cs unknown
- 1993-04-23 NZ NZ252847A patent/NZ252847A/en unknown
- 1993-04-23 BR BR9306733A patent/BR9306733A/pt not_active Application Discontinuation
- 1993-04-23 PL PL93307135A patent/PL307135A1/xx unknown
- 1993-04-23 SK SK46-95A patent/SK4695A3/sk unknown
- 1993-04-23 RU RU9595105159A patent/RU2097379C1/ru active
- 1993-04-23 AU AU55746/94A patent/AU669958B2/en not_active Ceased
- 1993-07-07 IL IL106264A patent/IL106264A0/xx unknown
- 1993-07-14 FI FI933203A patent/FI933203A/fi unknown
- 1993-07-14 CN CN93108457A patent/CN1083053A/zh active Pending
- 1993-07-14 HU HU9302018A patent/HUT68745A/hu unknown
- 1993-07-14 ZA ZA935076A patent/ZA935076B/xx unknown
- 1993-07-14 MX MX9304266A patent/MX9304266A/es not_active Application Discontinuation
-
1995
- 1995-01-13 NO NO950142A patent/NO950142L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL106264A0 (en) | 1993-11-15 |
| WO1994002480A1 (en) | 1994-02-03 |
| JPH07504684A (ja) | 1995-05-25 |
| MX9304266A (es) | 1994-01-31 |
| PL307135A1 (en) | 1995-05-02 |
| HU9302018D0 (en) | 1993-10-28 |
| CZ10195A3 (en) | 1995-09-13 |
| NO950142D0 (no) | 1995-01-13 |
| CN1083053A (zh) | 1994-03-02 |
| CZ280603B6 (cs) | 1996-03-13 |
| KR950702561A (ko) | 1995-07-29 |
| AU669958B2 (en) | 1996-06-27 |
| US5235054A (en) | 1993-08-10 |
| EP0650488A1 (en) | 1995-05-03 |
| NO950142L (no) | 1995-01-13 |
| RU95105159A (ru) | 1997-02-10 |
| FI933203A (fi) | 1994-01-16 |
| AU5574694A (en) | 1994-02-14 |
| NZ252847A (en) | 1996-07-26 |
| CA2140135A1 (en) | 1994-02-03 |
| BR9306733A (pt) | 1999-01-12 |
| FI933203A0 (fi) | 1993-07-14 |
| RU2097379C1 (ru) | 1997-11-27 |
| HUT68745A (en) | 1995-07-28 |
| ZA935076B (en) | 1995-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0562042A4 (en) | Quinoline, naphthyridine and pyridobenzoxazine derivatives | |
| ZA918539B (en) | Indane and quinoline derivatives | |
| GB9108547D0 (en) | Quinoline derivatives | |
| HU9303601D0 (en) | Imidazopyridine | |
| PL313133A1 (en) | Antibacterial and antilichenial oxathiazines and their oxides | |
| PH21385A (en) | 7-substituted quinoline and naphthyridine antibacterial agents | |
| HU9300545D0 (en) | Sulfobenzyil-substituted pyridone derivatives | |
| HK1011351A1 (en) | Quinoline derivatives | |
| NZ215868A (en) | Substituted naphthyridine and quinoline derivatives as antibacterial agents | |
| ZA93826B (en) | 7-Substituted quinolones and naphthyridones as antibacterial agents | |
| PL308671A1 (en) | Derivatives of 5-hydrazine quinolone exhibiting anti-microbial activity | |
| SK4695A3 (en) | Quinoline and naphthyridine derivatives and antibacterial agent on their basis | |
| PH25930A (en) | Tricyclic pyridinyl quinoline compounds their antibacterial agent and use thereof | |
| ZA933561B (en) | Quinoline derivatives and processes for preparing the same | |
| EP0554004A3 (en) | Cephem compounds and antibacterial agents | |
| GB9126438D0 (en) | New quinoline derivatives | |
| GB9509116D0 (en) | Antibacterial naphthyridine | |
| AU3395295A (en) | Alkaloids and their antiviral agents | |
| AU3648993A (en) | Imidazopyridine derivative and medicine | |
| EP0572235A3 (en) | Beta-carboline derivatives with anticholecystoquinine activity | |
| AU685671B2 (en) | New thiazolo{3,2-a}quinoline and thiazolo{3,2-a}naphthyridine derivatives | |
| EP0603755A3 (en) | Cephalosporin salts and processes for their preparation. | |
| HU9302808D0 (en) | 3-substituted quinoline-5-carboxylic acid derivatives | |
| GB9201427D0 (en) | Quinoline derivatives | |
| ZA902483B (en) | Quinolone derivatives,preparation processes thereof,and antibacterial agents containing the same |